Stocktoria
Edesa Biotech, Inc. EDSA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2008-08-25
Edesa Biotech, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -1946.7% | -2397.1% | -2288.6% | -386.0% | -571.9% |
| Net margin | — | — | — | — | — | -1935.3% | -2378.6% | -2203.7% | -395.2% | -374.7% |
| FCF margin | — | — | — | — | — | -1518.0% | -2359.4% | -2191.3% | -385.9% | -617.8% |
| Return on assets | -53.1% | -161.8% | -94.2% | -151.6% | -91.5% | -59.1% | -42.8% | -65.2% | -38.8% | -27.4% |
| Return on equity | -57.7% | -311.4% | -118.8% | -186.9% | -102.2% | -96.0% | -141.9% | -68.0% | -40.8% | -35.5% |
| Current ratio | 10.67 | 0.91 | 3.53 | 4.25 | 8.29 | 5.30 | 21.60 | 21.06 | 19.40 | 4.14 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.